Literature DB >> 11451365

Semenogelin, the main protein of semen coagulum, inhibits human sperm capacitation by interfering with the superoxide anion generated during this process.

E de Lamirande1, K Yoshida, T M Yoshiike, T Iwamoto, C Gagnon.   

Abstract

Semenogelin (Sg), the major protein of the human semen coagulum, is present at high concentrations in seminal vesicle secretions. It is degraded by the prostate-specific antigen (PSA) to generate peptides of various biological activities that were found on and inside spermatozoa. Our aim was to determine the effect of Sg on capacitation, which is the series of transformations that spermatozoa must undergo to become fertile. At concentrations of 0.1 to 1.0 mg/mL (600- to 20-fold lower than those of semen), Sg did not affect sperm motility (%) but completely prevented capacitation induced by fetal cord serum ultrafiltrate; a partial inhibition of capacitation was noted with 0.03 mg Sg/mL. There was also a dose-dependent decrease in the tyrosine phosphorylation of fibrous sheath proteins and in the O2-.-related chemiluminescence. Ribonuclease (RNase), which has as high an isoelectric point (pI = 9.7) as Sg (pI = 9.5), also prevented sperm capacitation and O2-.-related chemiluminescence but to a lower extent, suggesting that one mechanism of Sg action on spermatozoa could be related to its positive charge at physiological pH. Sg at 1, but not 0.3 or 0.1 mg/mL, scavenged the O2-. generated by the mix of xanthine + xanthine oxidase and modified the kinetics of the reaction; RNase did not have such effects. Therefore, Sg is a potential scavenger for O2-. but probably also affects the sperm oxidase. Spermatozoa rapidly processed Sg; a high proportion of Sg was degraded after 15 minutes of incubation. The resulting polypeptide patterns were reminiscent of those obtained with PSA as a proteolytic enzyme. These data suggest that Sg, its degradation products, or both may be natural regulators of sperm capacitation and could prevent this process from occurring prematurely. One mechanism by which Sg acts could involve an interference with the O2-. that is normally generated during this process.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11451365

Source DB:  PubMed          Journal:  J Androl        ISSN: 0196-3635


  36 in total

Review 1.  Semen analysis in laboratory practice: an overview of routine tests.

Authors:  Fernando Tadeu Andrade-Rocha
Journal:  J Clin Lab Anal       Date:  2003       Impact factor: 2.352

2.  Semenogelin I expression in myeloma cells can be upregulated pharmacologically.

Authors:  Yana Zhang; Zhiqing Wang; Jian Zhang; Benjamin Farmer; Seah H Lim
Journal:  Leuk Res       Date:  2008-05-12       Impact factor: 3.156

3.  Analysis of recombinant human semenogelin as an inhibitor of human sperm motility.

Authors:  Anurag Mitra; Richard T Richardson; Michael G O'Rand
Journal:  Biol Reprod       Date:  2009-11-04       Impact factor: 4.285

4.  Correlation of epididymal protease inhibitor and fibronectin in human semen.

Authors:  Xiangxiang Zhang; Jianzheng Fang; Bin Xu; Shengli Zhang; Shifeng Su; Zhen Song; Yunfei Deng; Hainan Wang; Dan Zhao; Xiaobing Niu; Zengjun Wang
Journal:  PLoS One       Date:  2013-12-16       Impact factor: 3.240

5.  Characterization of the proteomes associating with three distinct membrane raft sub-types in murine sperm.

Authors:  Atsushi Asano; Jacquelyn L Nelson; Sheng Zhang; Alexander J Travis
Journal:  Proteomics       Date:  2010-10       Impact factor: 3.984

6.  Reduced polymorphism in the chimpanzee semen coagulating protein, semenogelin I.

Authors:  Sarah B Kingan; Marc Tatar; David M Rand
Journal:  J Mol Evol       Date:  2003-08       Impact factor: 2.395

7.  Semenogelins in the human retina: Differences in distribution and content between AMD and normal donor tissues.

Authors:  Vera L Bonilha; Mary E Rayborn; Karen G Shadrach; Yong Li; Ake Lundwall; Johan Malm; Joe G Hollyfield
Journal:  Exp Eye Res       Date:  2007-10-25       Impact factor: 3.467

8.  Identification of protamine 1 as a novel cancer-testis antigen in early chronic lymphocytic leukaemia.

Authors:  Farouk Meklat; Yana Zhang; Masum Shahriar; Sharif U Ahmed; Wei Li; Nikolaos Voukkalis; Zhiqing Wang; Jian Zhang; Suhkrob Mastulov; Andrew Jewell; Thomas Giannakouros; Seah H Lim
Journal:  Br J Haematol       Date:  2008-11-22       Impact factor: 6.998

9.  Core promoter sequence of SEMG I spans between the two putative GATA-1 binding domains and is responsive to IL-4 and IL-6 in myeloma cells.

Authors:  Yana Zhang; Zhiqing Wang; Jian Zhang; Seah H Lim
Journal:  Leuk Res       Date:  2008-07-07       Impact factor: 3.156

10.  Inhibition of human sperm motility by contraceptive anti-eppin antibodies from infertile male monkeys: effect on cyclic adenosine monophosphate.

Authors:  Michael G O'Rand; Esther E Widgren; Stan Beyler; Richard T Richardson
Journal:  Biol Reprod       Date:  2008-10-22       Impact factor: 4.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.